Tim, I only see about 10% short interest in DBD. It looks real bad almost in all areas. The only redeeming features are dividend 3.85%, P/Sales .66, and next years earnings projections. Q/Q sales are bad and Q/Q earnings are worse. It ranks 17th out of 21 stocks in its industry group. Not much to like unless it is so bad things can only get better.
--------------------------billy
--------------------------billy
Comment